JB Pharma Sees 16% Profit Surge in Q2

JB Chemicals & Pharmaceuticals Ltd reported a 16% increase in profit after tax to Rs 175 crore in Q2 of 2024. Revenue rose by 13% to Rs 1,001 crore. JB Pharma's domestic and international projects saw significant growth, with expectations of maintaining positive momentum moving forward.

JB Chemicals & Pharmaceuticals Ltd announced a notable 16% increase in its profit after tax, reaching Rs 175 crore for the second quarter ending September 2024.

Compared to the previous year, the company had recorded a PAT of Rs 151 crore during the same period, based on the latest statement from JB Pharma.

Additionally, revenue surged by 13% to Rs 1,001 crore, outpacing the Rs 882 crore from Q2 of FY24. CEO Nikhil Chopra emphasized the strong domestic market performance and anticipated further growth internationally.

(With inputs from agencies.)